ResearchMoz

Browse All Autoimmune Market Research Reports

List of reports from Autoimmune

Displaying 1 to 14 (of 14 records)
Multiplexed Diagnostics Market (Technologies: Very High, High, Medium, Low Density Multiplexed Assays & Next-Generation Sequencing; Applications: Infectious Disease Diagnosis, Oncology, Autoimmune Diseases, Cardiac, Allergies and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Mar 2014   |   By - Transparency Market Research
This report covers the market analysis of the multiplexed diagnostics technologies namely, very high, high, medium, low density multiplexed assays & next-generation sequencing. This report contains qualitative information about oligonucleotide arrays, phage display, bacterial artificial chromosome arrays, protein arrays, bead-based arrays, antibody arrays, reverse arrays, mass...
$4795
Autoimmune Disorders - Pipeline Review, H2 2013
Jul 2013   |   By - Global Markets Direct
Global Markets Directs, Autoimmune Disorders - Pipeline Review, H2 2013, provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Autoimmune Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for...
$2000
Autoimmune Technologies, LLC - Product Pipeline Analysis, 2013 Update
May 2013   |   By - GlobalData
Summary Autoimmune Technologies, LLC (Autoimmune) is a biomedical company. The company develops medical diagnostic tests, explores disease mechanisms and investigates therapies for autoimmune diseases and disorders. It develops anti-viral drugs that are designed to prevent viral particles from fusing with target cells. Autoimmune also develops Flufirvitide, influenza drug a...
$750
Autoimmune Drugs Markets in China
May 2013   |   By - Asia Market Information & Development Company
China's demand for autoimmune drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012)...
$2000
Autoimmune Disorders - Pipeline Review, H1 2013
Feb 2013   |   By - Global Markets Direct
Global Markets Directs, 'Autoimmune Disorders - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Autoimmune Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for...
$2000
Acquired (Autoimmune) Hemolytic Anemia Pipeline Review, H2 2012
Nov 2012   |   By - Global Markets Direct
Global Markets Direct’s, 'Acquired (Autoimmune) Hemolytic Anemia Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Acquired (Autoimmune) Hemolytic Anemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key...
$2000
Autoimmune Disorders - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Autoimmune Disorders Pipeline Review, H2 2012 Global Markets Directs, 'Autoimmune Disorders Pipeline Review, H2 2012', provides an overview of the Autoimmune Disorders therapeutic pipeline. This report provides information on the therapeutic development for Autoimmune Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also...
$2500
Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments
Apr 2012   |   By - GBI Research
GBI Research, the leading business intelligence provider, has released its latest research Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments, which provides insights into autoimmune disease therapeutics market until 2017. The report is built using data and...
$3500
Endpoints - Clinical Trials in Autoimmune Disorders - Multiple Primary and Secondary Endpoints are Increasingly Being Applied to Ensure Success
Feb 2012   |   By - GBI Research
GBI Research, the leading business intelligence provider, has released its latest research, Endpoints - Clinical Trials in Autoimmune Disorders - Multiple Primary and Secondary Endpoints are Increasingly Being Applied to Ensure Success which provides an insight into different endpoints used in clinical trials in autoimmune disorders. The report examines different aspects of clinical trial...
$3500
Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market
Dec 2011   |   By - GBI Research
GBI Research, the leading business intelligence provider, has released its latest research Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market which provides insights about monoclonal antibodies sales forecasts until 2017. Monoclonal antibodies markets in the key geographies of the...
$3500
Orphan Autoimmune Disorders to 2017 - Strong Performance by Nplate and Promacta and Future Launches of Immunoglobulin Therapies will Drive the ITP Market
Nov 2011   |   By - GBI Research
GBI Researchs report, Orphan Autoimmune Disorders to 2017 - Strong Performance by Nplate and Promacta and Future Launches of Immunoglobulin Therapies will Drive the ITP Market provides in-depth analysis of the drivers and barriers that affect the global orphan autoimmune disorders. The report analyzes the markets for orphan autoimmune disorders therapeutics in the US, the top five...
$3500
Autoimmune Technologies, LLC - Product Pipeline Analysis
Nov 2011   |   By - GlobalData
Autoimmune Technologies, LLC (Autoimmune) is a biomedical company, based in the US. The company develops medical diagnostic tests, explores disease mechanisms, and investigates therapies for autoimmune diseases and other disorders. It also develops an influenza drug, a blood test to aid in the diagnosis of Lassa fever, fibromyalgia, systemic lupus erythematosus, Sjogren's syndrome,...
$750
Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade
Sep 2011   |   By - GBI Research
GBI Research, the leading business intelligence provider, has released its latest research Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment per Trial has Continued to Decline Over the Past Decade which provides an insight into clinical trial and patient recruitment in Autoimmune Disorders. The report examines different aspects concerning clinical trial and...
$3500
Chinese Markets for Autoimmune Drugs
Feb 2009   |   By - Asia Market Information & Development Company
China's demand for Autoimmune Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and...
$4000
 
Displaying 1 to 14 (of 14 records)

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData

Popular Categories

 

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com

Upcoming Reports